Home Ventilatory Support in Children
- Conditions
- Sleep Apnea Syndromes in Children
- Registration Number
- NCT06172868
- Lead Sponsor
- Tampere University Hospital
- Brief Summary
The study consist of children, who have used home ventilatory support during years 2010-2020 in Tampere University Hospital. The study will describe retrospectively different diagnoses and symptoms which will lead to home ventilatory support. We also study compliance to treatment and it's disanvantages. The prospective part of the study describes the quality of live of these children by using questionnaires (PedSQL).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 94
- ICD-10 Code for Sleep apnea diagnose G47.3 AND G47.3 diagnose found from pediatric electronic patient records between years 2010-2020 OR Patient name found from pediatric multidisciplinary home respiratory team's clinical list
- Age over 16
- Patient starting home ventilation after 31st December 2020 or treatment ending before 1st January 2010
- patients with sleep apnea but without home respiratory support treatment
- Only theophylline treatment
- High-flow oxygen therapy
- Age over 16 at treatment onset
- Never started treatment
- Treatment starting point and ending before year 2010
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient demographics of patients from 0 up to 16 years old treated by a multidisciplinary home respiratory support-team during January 2010 to December 2020 in Tampere University Hospital, Finland 2022-2023 Data included patient demographics
Number of patients with clinical characteristics 2022-2023 Data included underlying medical conditions and medications. The circumstances for home respiratory support onset, frequency of follow-up, complications, operative interventions to treat sleep apnea before and during period with home respiratory support were collected. The type of respiratory support (device, mode, interface) was recorded.
- Secondary Outcome Measures
Name Time Method The duration of treatment 2022-2023 The duration of treatment during January 2010 to December 2020 in Tampere University Hospital, Finland were collected.
Trial Locations
- Locations (1)
Mervi Järvelä
🇫🇮Ilmajoki, Finland